Your browser doesn't support javascript.
loading
Evolution of liver transplant organ allocation policy: Current limitations and future directions.
Polyak, Alexander; Kuo, Alexander; Sundaram, Vinay.
Afiliación
  • Polyak A; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, United States.
  • Kuo A; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, United States.
  • Sundaram V; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, United States. vinay.sundaram@cshs.org.
World J Hepatol ; 13(8): 830-839, 2021 Aug 27.
Article en En | MEDLINE | ID: mdl-34552690
ABSTRACT
Since the adoption of the model for end-stage liver disease (MELD) score for organ allocation in 2002, numerous changes to the system of liver allocation and distribution have been made with the goal of decreasing waitlist mortality and minimizing geographic variability in median MELD score at time of transplant without worsening post-transplant outcomes. These changes include the creation and adoption of the MELD-Na score for allocation, Regional Share 15, Regional Share for Status 1, Regional Share 35/National Share 15, and, most recently, the Acuity Circles Distribution Model. However, geographic differences in median MELD at time of transplant remain as well as limits to the MELD score for allocation, as etiology of liver disease and need for transplant changes. Acute-on-chronic liver failure (ACLF) is a subset of liver failure where prevalence is rising and has been shown to have an increased mortality rate and need for transplantation that is under-demonstrated by the MELD score. This underscores the limitations of the MELD score and raises the question of whether MELD is the most accurate, objective allocation system. Alternatives to the MELD score have been proposed and studied, however MELD score remains as the current system used for allocation. This review highlights policy changes since the adoption of the MELD score, addresses limitations of the MELD score, reviews proposed alternatives to MELD, and examines the specific implications of these changes and alternatives for ACLF.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: World J Hepatol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: World J Hepatol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos